March 12th 2024, 3:00pm
Artificial intelligence platform ChatGPT is capable of providing “widely understandable and accessible” answers about kidney cancer, but experts express caution.
March 12th 2024, 1:00pm
My prostate cancer has come back and stronger, but so have I.
March 7th 2024, 5:29pm
The Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with cisplatin and gemcitabine for the first-line treatment of adults with unresectable or metastatic bladder cancer, the agency has announced.
February 27th 2024, 10:00pm
A phase 2 trial showed that Trodelvy plus Keytruda had a high response rate with lasting responses, emphasizing “potential additive or synergistic effects,” an expert said.
February 27th 2024, 6:00pm
Looking back on my experience with testicular cancer at a young age, I realize that cancer didn't define me — it helped shape me.
February 27th 2024, 2:00pm
Patients with locally advanced penile squamous cell carcinoma who responded to neoadjuvant chemotherapy followed by consolidative lymphadenectomy experienced improved long-term survival outcomes.
February 16th 2024, 4:00pm
From International Childhood Cancer Day to an Ivory Coast soccer player making a victorious comeback after testicular cancer, here’s what is happening in the oncology space this week.
January 19th 2024, 2:00pm
A 45-minute cancer procedure deemed me to be "cancer free," but it did not assuage all my anxieties.
January 16th 2024, 2:00pm
From Tom Green to Deadpool, humor-based messaging has long been utilized for testicular cancer. Researchers aren’t sure how effective that strategy is.
November 25th 2023, 7:00pm
In honor of Men’s Health Awareness Month, CURE® looked back on some of the most significant news within the oncology space.
Weight Gain as a Side Effect of Lung Cancer Targeted Therapy
Understanding Your Early-Stage Lymphoma Diagnosis
Understanding Lung Cancer Trial Results and Their Treatment Impact
He Preached Early Detection; Then It Saved His Life